[Evidence-based management of diabetic polyneuropathy. "Burning feet" alarm signal].
Wepner
Ulrike
U
D000588:Amines / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use; D017719:Diabetic Foot / Q000175:diagnosis* / Q000628:therapy; D003929:Diabetic Neuropathies / Q000175:diagnosis* / Q000628:therapy; D018450:Disease Progression; D019317:Evidence-Based Medicine; D000077206:Gabapentin; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D010147:Pain Measurement; D010292:Paresthesia / Q000175:diagnosis* / Q000628:therapy; D008063:Thioctic Acid / Q000627:therapeutic use; D005680:gamma-Aminobutyric Acid / Q000627:therapeutic use
D000588:Amines; D003509:Cyclohexanecarboxylic Acids; D000077206:Gabapentin; D006442:Glycated Hemoglobin; D008063:Thioctic Acid; D005680:gamma-Aminobutyric Acid